KUALA LUMPUR, 02 FEBRUARY 2021 – Ho Wah Genting Berhad (“HWGB” or the “Company”) (Bursa Stock Code: 9601), through its wholly-owned subsidiary HWGB Biotech Sdn Bhd (“HWGB Biotech”) has been successfully granted the Pharmacist’s Poisons Licence (Type A License) from the Pharmaceutical Services Division of Ministry of Health Malaysia which enable the Company to import, store and deal generally by wholesale all controlled medicine (termed as poison according to Poisons Act Malaysia).
General Manager, Medical & Pharmaceutical Research of HWGB Biotech, Dr.Yaman Walid Kassab expressed: “We are delighted to have obtained the license which make us qualify to handle import and distribute our healthcare products in compliance with the MOH regulations. This license shows that we are committed in our healthcare related business and we believe that this license can bring a huge growth potential to HWGB as well”.
“With the granted license, we believe that the consumer will be able to trust the product that we are going to distribute such as vaccines and controlled medicine. This is because only a pharmacist registered with the Pharmacy Board of Malaysia or a qualified pharmacist recognized by the state health directors of Sabah or Sarawak is able to hold for such license” he added.
Ho Wah Genting Berhad (“HWGB” or the “Company”) is principally engaged in investment holdings and the provision of management services to its subsidiaries. The Company had on 30 June 2020 diversified its existing businesses to include healthcare-related industry which mainly involved in Health Supplement, Biotechnology and Health Technology. In addition, the Company and its subsidiaries (“HWGB Group” or the “Group”) are also engaging in the businesses of Investment holdings; manufacturing of wires and cables and moulded power supply cord sets and cable assemblies for electrical and electronic devices and equipment; Trading of wires and cables; and travel agent and tour related services.
HWGB Biotech Sdn Bhd, was incorporated on 18 June 2012 under the Companies Act, 1965 under the former name of HWG Consortium Sdn Bhd and changed to its current name on 22 May 2020. HWGB Biotech is principally involved in the distribution of all kinds of biotechnology products, bioinformatics diagnostic tools, all medical engineering equipment along with software developments and tools as well as to patent all original products and by-products, technologies and software developed or sourced by the company.
For more information about HWGB Biotech, follow us on https://hwgbbiotech.com, http://subscription.hwgbbiotech.com, Facebook, LinkedIn, and Telegram to view the latest updates about our company ventures in the healthcare industry